Month: June 2024
Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th Scientific Session
BURLINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced that Dr. Harith Rajagopalan, CEO of Fractyl Health, and Dr. Timothy Kieffer, CSO of Fractyl Health, will participate in a virtual fireside chat at the upcoming Piper Sandler 2nd Annual Virtual Obesity Day on Wednesday, June 26, 2024 at 9:30 a.m. EDT.
The Company will discuss the acceleration of its weight maintenance clinical study, which it recently announced, as well...
Skye BioScience Participating in Piper Sandler Virtual Obesity Day
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that it will participate in the Piper Sandler Virtual Obesity Day with ADA 2024 Conference Takeaways on Wednesday, June 26, 2024. The event includes presentations by KOLs and fireside chats with companies developing obesity therapeutics. Piper Sandler clients can register for the event through their representative.
Skye Bioscience Fireside Chat11:30-11:55 a.m. ETSkye Participants:Punit Dhillon, CEO & Chair
Tu Diep, MSc, Chief Development Officer
Chris Twitty, PhD, Chief Scientific OfficerAbout Skye Bioscience...
BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia
Written by Customer Service on . Posted in Public Companies.
Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose)
For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatment
Results supportive of Phase 3 SERENITY and TRANQUILITY programs
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced positive topline results from a post-marketing requirement (PMR) study of IGALMI™ (dexmedetomidine) sublingual film that demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with the 180 mcg dose after seven days of PRN...
West Red Lake Gold Strengthens Management Team
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 25, 2024 (GLOBE NEWSWIRE) — West Red Lake Gold Mines Ltd. (“West Red Lake Gold” or “WRLG” or the “Company”) (TSXV: WRLG) (OTCQB: WRLGF) is pleased to announce the appointment of Jason Billan as Vice President Corporate Development effective June 24, 2024.
Mr. Billan has spent 15 years in the mining sector, with an emphasis on corporate development, strategy, financing, and executive leadership. Following an MBA at the University of Western Ontario in 2009, he spent three years in precious metals equity research at Salman Partners and RBC Capital Markets, with a coverage universe ranging from small exploration companies to large producers. In 2012, he joined Nevsun Resources as a corporate development analyst. In 2016 Nevsun acquired the Timok copper-gold project in Serbia for over US$500M before...
First Atlantic Nickel Identifies 30km Awaruite Nickel Trend From Data Compilation at its Atlantic Nickel Project in Central Newfoundland
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 25, 2024 (GLOBE NEWSWIRE) — First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or “FAN” or the “Company”) is pleased to announce it has completed a large-scale data compilation for its 21,850-hectare Atlantic Nickel Project in Central Newfoundland, Canada. This first-time extensive review, covering the entire Pipestone Ophiolite Ultramafic Complex, identified over 700 regional exploration reports. Of these, 134 contained relevant project information, including data on prospecting, geological mapping, airborne geophysics, geochemistry, and drilling.
The data compilation program outlined a 30-km core trend with consistent, highly anomalous nickel concentrations, strongly correlating with the Pipestone Complex’s high-magnetic ultramafic rocks. These rocks have...
Robinson Capital Announces Quarterly Distributions on $SPAX
Written by Customer Service on . Posted in Dividend Reports And Estimates.
GROSSE POINTE FARMS, Mich., June 25, 2024 (GLOBE NEWSWIRE) — Robinson Capital today announced quarterly distributions on the Robinson Alternative Yield Pre-Merger SPAC ETF (SPAX).
Distribution as of 06/25/2024ETFTicker
Distributionper Share
Ex-Date
RecordDate
PaymentDateSPAX
$0.27
06/26/2024
06/26/2024
06/28/2024SPAX, launched in partnership with Tidal Investments LLC, is an actively managed exchange-traded fund (ETF) that invests primarily in pre-merger Special Purpose Acquisition Companies (SPACs), which offer the potential for mitigating downside risk and capturing upside opportunity. SPAX seeks to provide total return while minimizing downside risk.
About Robinson CapitalFounded in 2012, Robinson Capital Management is an independent investment advisor specialized in developing both traditional and alternative fixed...
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
Written by Customer Service on . Posted in Public Companies.
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer effective June 27. In this role, John will lead the Company’s US sales team with the objective of maximizing the positive impact of Barostim therapy on patients suffering from heart failure and establishing Barostim as standard of care in the United States.
“We are thrilled to welcome Robert to the CVRx executive team as we continue to expand the adoption of Barostim therapy,” said Kevin Hykes, President and CEO of CVRx. “Robert is well-known and respected within the heart failure community and has extensive experience building global sales organizations, launching novel heart failure therapies, and...
TransUnion Announces Earnings Release Date for Second Quarter 2024 Results
Written by Customer Service on . Posted in Public Companies.
CHICAGO, June 25, 2024 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) will publish its financial results for the second quarter ended June 30, 2024, in a press release to be issued at approximately 6:00 a.m. Central Time (CT) on Thursday, July 25, 2024. The company will hold a conference call on the same day at 8:30 a.m. Central Time (CT) to discuss its financial results. The press release and a live webcast of the earnings conference call will be available on the TransUnion Investor Relations website at http://www.transunion.com/tru.
About TransUnion (NYSE: TRU)
TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable...
First Quantum Provides Notice of Second Quarter 2024 Results
Written by Customer Service on . Posted in Public Companies.
TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) will release second quarter 2024 financial and operating results on Tuesday, July 23, 2024 after the close of the Toronto Stock Exchange. The Company will host a conference call and webcast to discuss the results on Wednesday, July 24, 2024 at 9:00 am (ET).
Conference call and webcast details:Toll-free North America: 1-844-763-8274Toll-free International: +1-647-484-8814Webcast: Direct link or on our website
A replay of the webcast will be available on the First Quantum website.
For further information, visit our website at www.first-quantum.com or contact:
Bonita To, Director, Investor Relations (416) 361-6400 Toll-free: 1 (888) 688-6577E-Mail: info@fqml.com
Azimut Announces Discovery of Spodumene Pegmatites at Pilipas, James Bay Region, Quebec
Written by Customer Service on . Posted in Public Companies.
LONGUEUIL, Québec, June 25, 2024 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to report the discovery of spodumene bearing pegmatite outcrops on the Pilipas Property (the “Property”) in the Eeyou Istchee James Bay region of Quebec, Canada (Figure 1). Ophir Metals Corp. (formerly Ophir Gold Corp.) (“Ophir”) (TSXV: OPHR) (OTCQB: OPHRF), as operator under the option agreement, is completing an inaugural lithium-focused surface exploration program on the Property (see press releases of December 11, 2023 and May 14, 2024).
HIGHLIGHTS (see Figure 2)A spodumene bearing pegmatite occurrence was discovered on the Property at the Highway showing (“HW1”).
This spodumene pegmatite is open in multiple directions with an approximate strike length of over 150 m and width of up...
